MASH

Metabolic dysfunction-associated steatohepatitis (MASH), previously known as nonalcoholic steatohepatitis (NASH).

stock market down market bear market benny
Biotech

Galectin's stock halves after phase 3 MASH trial misses goal

Since the biotech shared the phase 3 data this morning, the company’s stock has dropped 54%, from $2 per share to 92 cents.
Gabrielle Masson Dec 20, 2024 2:40pm
two jiggsaw puzzles connected with drawn hands shaking on the two puzzles

VC firm pens $608M deal to direct NGM MASH drug to rare disease

Dec 19, 2024 10:30am
Liver disease

Viking liver disease drug reduces fibrosis in final ph. 2 data

Nov 20, 2024 3:20pm
An arrow incrementally going up stairs before pointing straight up Blue background

Boston's monthly MASH prospect hits goal in phase 2

Nov 15, 2024 11:00am
liver

Gilead gives up on $15M MASH bet after mulling preclinical data

Oct 11, 2024 10:28am
proclaim red announcement

Aligos MASH prospect slashes liver fat in phase 2

Sep 19, 2024 1:00pm